Boiron SA
PAR:BOI

Watchlist Manager
Boiron SA Logo
Boiron SA
PAR:BOI
Watchlist
Price: 26.7 EUR 3.09%
Market Cap: 468.6m EUR
Have any thoughts about
Boiron SA?
Write Note

Gross Margin
Boiron SA

72.8%
Current
72%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.8%
=
Gross Profit
350.9m
/
Revenue
481.7m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
FR
Boiron SA
PAR:BOI
463.6m EUR
73%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
US
Eli Lilly and Co
NYSE:LLY
756.2B USD
81%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK
85%
US
Johnson & Johnson
NYSE:JNJ
351.2B USD
69%
US
Merck & Co Inc
NYSE:MRK
251.2B USD
77%
CH
Roche Holding AG
SIX:ROG
200.1B CHF
73%
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP
82%
CH
Novartis AG
SIX:NOVN
171.5B CHF
75%
US
Pfizer Inc
NYSE:PFE
151.1B USD
71%
Country FR
Market Cap 463.6m EUR
Gross Margin
73%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 351.2B USD
Gross Margin
69%
Country US
Market Cap 251.2B USD
Gross Margin
77%
Country CH
Market Cap 200.1B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 171.5B CHF
Gross Margin
75%
Country US
Market Cap 151.1B USD
Gross Margin
71%
No Stocks Found

Boiron SA
Glance View

Market Cap
463.6m EUR
Industry
Pharmaceuticals

Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

BOI Intrinsic Value
38.6 EUR
Undervaluation 31%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.8%
=
Gross Profit
350.9m
/
Revenue
481.7m
What is the Gross Margin of Boiron SA?

Based on Boiron SA's most recent financial statements, the company has Gross Margin of 72.8%.